发明名称 2-OXO-1-PYRROLIDINE DERIVATIVES, METHOD OF OBTAINMENT
摘要 FIELD: chemistry. ^ SUBSTANCE: invention concerns levorotatory enantiomer for compound of the formula (B) and its pharmaceutically acceptable salts, where R1 is methyl, X is -COOMe; and levorotatory enantiomer for compound of the formula (B) and its pharmaceutically acceptable salts, where R1 is methyl, X is -COOEt. Additionally invention concerns methods of obtaining indicated enantiomers by asymmetrical hydration of respective source compounds in the form of Z and E isomers. ^ EFFECT: intermediary compounds for obtainment of levetiracetam medicine. ^ 4 cl, 4 tbl, 8 ex
申请公布号 RU2355680(C2) 申请公布日期 2009.05.20
申请号 RU20060125756 申请日期 2001.02.21
申请人 JUSIBI FARSHIM S.A. (AG-LTD) 发明人 SARTIS DZHON;MARMON VIOLETA;DIFFERDEHN EHDMON;ZIMMERMANN VINSENT
分类号 C07D401/04;A61K31/4015;A61K31/4025;A61K31/41;A61K31/4178;A61K31/4188;A61K31/4192;A61K31/4196;A61K31/422;A61K31/4245;A61K31/427;A61K31/433;A61K31/4439;A61K31/497;A61K31/506;A61K31/541;A61P9/00;A61P9/06;A61P9/10;A61P11/00;A61P11/06;A61P21/00;A61P25/00;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P27/16;A61P37/08;C07B61/00;C07C237/06;C07C237/12;C07D207/26;C07D207/27;C07D207/273;C07D207/277;C07D307/33;C07D401/06;C07D403/04;C07D403/06;C07D403/12;C07D405/04;C07D409/04;C07D413/04;C07D417/04;C07D495/04 主分类号 C07D401/04
代理机构 代理人
主权项
地址